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Abstract 
Objective: To investigate the possible influence of risk factors on seizure outcome after surgery 
for drug-resistant temporal lobe epilepsy (TLE) and mesial temporal sclerosis (MTS).  
Methods: This retrospective study recruited patients with drug-resistant MTS-TLE who 
underwent epilepsy surgery at Jefferson Comprehensive Epilepsy Center and were followed for a 
minimum of one year. Patients had been prospectively registered in a database from 1986 
through 2014. Post-surgical outcome was classified into two groups; seizure free or relapsed. 
The possible risk factors influencing long-term outcome after surgery were investigated. 
Results: 275 patients with MTS-TLE were studied. Two-thirds of the patients had Engel’s class 
1 outcome and 48.4% of the patients had sustained seizure freedom, with no seizures since 
surgery. Patients with a history of tonic-clonic seizures in the year preceding surgery were more 
likely to experience seizure recurrence (odds ratio 2.4; 95% CI: 1.19-4.80; p = 0.01). Gender, 
race, family history of epilepsy, history of febrile seizure, history of status epilepticus, duration 
of disease before surgery, intelligence quotient, and seizure frequency were not predictors of 
outcome. 
Conclusions: Many patients with drug-resistant MTS-TLE respond favorably to surgery. It is 
critical to distinguish among different types and etiologies of TLE when predicting outcome after 
surgery.    
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Introduction 
Focal epilepsies account for about two-thirds of all adult patients with epilepsy, and 
temporal lobe epilepsy (TLE) is the most common type of focal epilepsy 1, 2. Mesial temporal 
sclerosis (MTS) is the most common pathological substrate of TLE 3 and about 70% of patients 
with drug-resistant TLE show signs of MTS on their MRI 4. Temporal lobe epilepsy is the most 
common type of drug-resistant epilepsy referred for epilepsy surgery; it often responds favorably 
to surgery 5, 6. The potential efficacy of resective surgery in patients with TLE uncontrolled by 
anti-epileptic drugs is undisputed. However, there are still uncertainties about which patients will 
benefit most 7. Various centers use different methodologies in their research. In addition, they 
often report the combined results from patients with TLE due to MTS and other etiologies as 
well as nonlesional patients. Such discrepancies may explain the wide variation in seizure free 
rates after surgery for TLE and they may also obfuscate factors that influence postoperative 
seizure outcome in these patients 6, 7. 
In order to obtain a clearer picture of the possible influence of risk factors on 
postoperative seizure outcome for patients with drug-resistant MTS-TLE, we conducted a 
retrospective study of a large surgical cohort. We examined seizure outcome during long-term 
postsurgical follow-up in patients with magnetic resonance imaging (MRI)-proven MTS-TLE 
who had undergone epilepsy surgery for drug-resistant seizures. This may shed light on the 
significance of distinguishing specific types and etiologies of TLE when predicting outcome 
after surgery. 
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Material and methods  
In this retrospective study, we examined data from all patients with a clinical diagnosis of 
drug-resistant MTS-TLE who underwent epilepsy surgery at Jefferson Comprehensive Epilepsy 
Center between 1986 and 2014 and had a minimum of 1-year postoperative follow-up. Historical 
data was obtained by board certified neurologists. The diagnosis of TLE was made by the 
epileptologists working at this institution and based on clinical grounds (history and semiology) 
and electroencephalographic (EEG) findings, in order to retain the diagnosis of mesial TLE. 
There was no age limit to enter the study. All patients underwent a comprehensive presurgical 
evaluation including a brain MRI, prolonged video-EEG monitoring, neuropsychological 
evaluation, etc. Magnetic resonance imaging studies were analyzed by neuroradiologists, 
neurologists, and neurosurgeons with expertise in epilepsy in order to ascertain the diagnosis of 
MTS. A positive MRI scan for evidence of MTS was required for inclusion in the study. We 
classified patients as having MTS if they had clear signs of mesial temporal atrophy and/or 
sclerosis in their brain MRI. Pathology specimens were reviewed by pathologists, but most 
results were not sufficient to make a precise pathological classification. Patients with dual 
pathology (in their MRI) and also patients with incomplete data with regard to pre- and post-
operative seizure information (i.e., type and frequency) were excluded from this study.  
All patients included in the analysis had an anterior temporal lobectomy (ATL). 
Resections have evolved over the years, but there has been no difference in treatment strategy. 
Early on, we performed lateral resections in the dominant hemisphere 4 cm from the pole; more 
recently these resections were performed 2-3 cm from the pole. In the nondominant hemisphere, 
early on we performed lateral resections 5 cm from the pole; more recently 3-4 cm from the pole. 
In mesial resections there was no difference in resection size between dominant and 
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nondominant foci. The patients were followed for at least one year and up to five years after 
surgery (for many patients the data were missing beyond five years of follow-up). Seizure 
outcome was monitored periodically by office visits (by the treating physician), telephone 
contacts, and letters (by the nurse practitioners). Postsurgical outcome was classified into two 
groups; with sustained seizure freedom or relapsed (one or more seizures after surgery) for the 
purpose of time to event analysis (Kaplan-Meier estimate of seizure recurrence) and Cox-Mantel 
test. Aura was not considered as a relapse; only postoperative tonic-clonic seizures and complex 
partial seizures were considered as relapse. We also used Engel’s scale to rate the postoperative 
seizure outcome. 
Age, gender, race, epilepsy risk factors [e.g., history of febrile seizures in childhood, any 
family history of epilepsy (i.e., first, second, or third degree), etc.], age at seizure onset (i.e., the 
first afebrile habitual seizure), seizure type(s) and history, date of surgery, date of the first 
relapse (if any) and date of the last contact with all patients were registered routinely. The type 
and number of febrile seizures was not registered, so only their presence or absence based on 
history could be obtained.  A history of febrile seizures is registered base on history and details 
are not only often unavailable, but would be unreliable because of the retrospective nature of 
these reports. 
Demographic variables and relevant clinical variables were summarized descriptively to 
characterize the study population. Potential outcome predictors, including gender, age at surgery, 
duration of epilepsy, race, history of status epilepticus before surgery, history of tonic-clonic 
seizures before surgery, history of febrile seizures in childhood, family history of epilepsy, full 
scale intelligence quotient (IQ), and preoperative seizure frequency were assessed comparing 
seizure free and non-seizure free patients, who happened to have similar duration of 
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postoperative follow-up (4.1 ± 1.3 vs. 4.4 ± 1.1 years, respectively). Initially, we performed 
univariate analyses using Pearson Chi-square, Mann-Whitney, Kolmogorov-Smirnov, and t-test.  
Variables that were significant or nearly so in univariate tests were assessed in a logistic 
regression. Time to event analysis was used to produce a Kaplan-Meier estimate of seizure 
recurrence. A Kaplan-Meier analysis allows estimation of event over time, even when patients 
drop out or are studied for different lengths of time. Cox-Mantel test was used to study annual 
rate of occurrence of first seizure after resective epilepsy surgery in different groups of patients. 
Odds ratio and 95% confidence interval (CI) were calculated. P value less than 0.05 was 
considered as significant. No informed consent was required, as it was a retrospective study. This 
study was conducted with the approval by Thomas Jefferson University Institutional Review 
Board. 
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Results 
From 1986 until 2014, 789 patients had anterior temporal lobectomy at our center; 770 
patients had at least one year of follow-up. Of these, 309 patients had MTS in their MRI, 251 
patients had other abnormalities (e.g., tumor, gliosis, vascular lesion, etc.) in their MRIs, 168 
patients had a normal MRI, 19 patients had dual pathology and MRI was not available in 23 
patients. Among patients with MTS, 34 patients had incomplete data; 275 patients (132 males 
and 143 females) had MTS-TLE with at least one year of postoperative follow-up and complete 
seizure data; these were studied. One hundred thirty-three (48.4%) patients had sustained seizure 
freedom and 142 (51.6%) patients experienced one or more seizures after surgery. When we 
classified postoperative seizure outcome according to Engel’s scale, 259 patients had available 
data; of these, 172 patients (66.4%) were seizure free (Engel’s class 1 outcome). For the 
statistical purposes, we considered 133 patients as seizure free (those with sustained seizure 
freedom; see above), as in this long-term postsurgical follow-up study some patients dropped out 
or were studied for different lengths of time. Univariate analyses of risk factors for recurrence of 
postoperative seizures appear in Table 1. The analysis revealed an association between a history 
of preoperative tonic-clonic seizures and postoperative seizure recurrence. Preoperative seizure 
frequency was also associated with seizure outcome. Subsequent logistic regression analysis to 
assess these variables showed that a history of preoperative tonic-clonic seizures in the year 
preceding surgery was a strong predictor, and the only predictor, of postoperative seizure 
recurrence (Figure 1). Frequency of complex partial seizures (p = 0.2) or tonic-clonic seizures (p 
= 0.1) was not a significant risk factor. Patients who had recent preoperative tonic-clonic seizures 
(i.e., in the year preceding surgery) had a greater chance of seizure recurrence than those without 
such a history (odds ratio 2.4; 95% CI: 1.19-4.80; p = 0.01). The model correctly predicted 
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58.5% of the cases of relapse. However, a remote history of preoperative tonic-clonic seizures 
was not a risk factor for seizure recurrence. Among patients who had a remote history of 
preoperative tonic-clonic seizures (i.e., not within the year preceding their surgery), chance of 
having postoperative seizure recurrence was similar to those who did not have any preoperative 
tonic-clonic seizures (odds ratio: 1.31, 95% CI: 0.74-2.31; p = 0.3). Total preoperative seizure 
frequency (complex partial seizures plus tonic-clonic seizures) was calculated and patients were 
dichotomized into those with less than 20 seizures per month versus patients with 20 or more 
seizures per month; this was not related to outcome (p = 0.9). In addition, epilepsy duration (less 
than 20 years compared to more than 20 years of epilepsy) did not influence outcome (p = 0.5). 
In a subanalysis, we studied patients who were seizure free and aura free for one year or 
more in their last follow-up visit (77 patients) compared with those who had any seizures or 
auras (198 patients); this subanalysis did not affect the results. A history of preoperative tonic-
clonic seizures (p = 0.005) and also preoperative tonic-clonic seizure frequency (p = 0.002) were 
associated with outcome in univariate analyses. We then performed a logistic regression analysis, 
assessing these variables. A history of preoperative tonic-clonic seizures in the year preceding 
surgery showed a trend in predicting postoperative seizure recurrence. Recent preoperative tonic-
clonic seizures (i.e., in the year preceding surgery) were associated with a greater chance of 
seizure recurrence (odds ratio 2.15; 95% CI: 0.96-4.82; p = 0.06). The model correctly predicted 
71.9% of the cases of relapse. 
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Discussion 
Drug-resistant temporal lobe epilepsy is a relatively common type of epilepsy that often 
responds favorably to surgery. In our study, about half of the patients had sustained seizure 
freedom during a long-term postsurgical follow-up, which is concordant with most previous 
studies 6, 7, 10, 11. This study aimed to resolve ambiguities regarding the prognostic value of 
historical risk factors in drug-resistant TLE after surgery in patients with MTS. We found that a 
history of recent preoperative tonic-clonic seizures was associated with postoperative seizure 
recurrence. 
 
1. History of febrile seizures in childhood 
A history of febrile seizure in the past did not predict the postoperative outcome in patients 
with drug-resistant MTS-TLE. A previous meta-analysis of predictors of temporal lobectomy 
outcome in a heterogeneous population of TLE patients found febrile seizures to be a strong 
prognostic indicator of seizure remission (odds ratio 0.48; 95% confidence interval 0.27–0.83) 7. 
However, other studies that only included patients with MTS found that a history of febrile 
seizure in childhood did not predict the seizure outcome after surgery 12, 13; our study findings are 
concordant with these studies. Febrile seizures are strongly associated with MTS, which itself is 
associated with a favorable prognosis. However, as an independent predictor, febrile seizure only 
predicts outcome when MTS is one of many underlying pathologies in patients with diverse 
etiologies for their epilepsy. It loses its predictive value when the subgroup of patients with MTS 
is examined 13. Febrile seizures are clearly related to MTS at times 14. MRI findings of a 
markedly hyperintense hippocampus in children with febrile status epilepticus was highly 
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associated with later development of mesial temporal sclerosis 14, 15. It appears that it is critical to 
distinguish among different types and etiologies of TLE when predicting outcome after surgery. 
 
2. History of tonic-clonic seizures 
In our study, the only factor predictive of seizure outcome after surgery in patients with 
drug-resistant MTS-TLE was the occurrence of tonic-clonic seizures, if there were any in the 
year preceding surgery. When MRI or pathology clearly shows MTS, then preoperative tonic-
clonic seizures reduce the chance of postoperative seizure freedom 12. Another study with a more 
heterogeneous population of 280 patients who underwent anterior temporal lobectomy also 
associated a history of secondary generalized tonic-clonic seizure(s) with a lower probability of 
becoming seizure free (odds ratio 0.47, 95% CI 0.25-0.90; p = 0.02) 16. Another study of 339 
patients followed for more than 2 years found that absence of generalized tonic-clonic seizures 
and presence of hippocampal atrophy on MRI were significantly associated with remission in 
patients with medial temporal resection 17. Recent tonic-clonic seizures in a patient with MTS 
may reflect more widespread epileptogenicity extending beyond the borders of mesial temporal 
structures. Evidence obtained with fMRI suggests significant, more widespread derangements in 
brain function and connectivity in TLE patients with tonic-clonic seizures (compared with those 
without this seizure type) 18.   
 
3. Duration of epilepsy before surgery  
Duration of epilepsy before surgery is determined by age at the onset of epilepsy and age 
at surgery. In our study, duration of epilepsy did not predict seizure outcome after epilepsy 
surgery in patients with drug-resistant MTS-TLE. Another study of 116 consecutive patients who 
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had temporal lobe surgery for drug-resistant epilepsy and MTS reported similar observations to 
ours 12. In contrast, another retrospective study which included 434 consecutive adult patients 
who underwent TLE surgery found that longer epilepsy duration correlated with poor outcome 9. 
These authors investigated a heterogeneous group of patients including those with MTS and 
others with tumors or focal cortical dysplasia. As in other variables, better definition of the 
location within the temporal lobe of the epileptogenic zone may provide better insights.  
 
4. Intelligence quotient (IQ) 
In our study, IQ did not predict postoperative seizure outcome in patients with MTS-
TLE. In one previous study, the authors examined the relationship between baseline IQ scores 
and seizure outcome in 1,034 temporal lobectomy cases from eight epilepsy surgery centers 19. 
Those patients who continued to have seizures following surgery had statistically lower 
preoperative IQ scores than those who were seizure free (p < 0.009), but only by 2.3 points. 
There was considerable overlap between the two groups. However, relative risk analyses 
revealed no significant increase in risk of surgical failure among patients with low IQ scores who 
had no structural lesions other than mesial temporal sclerosis 19. This is consistent with our 
findings. However, another study that included all resective epilepsy surgeries found a 
significant relationship between IQ and seizure freedom, with a higher IQ associated with a 
better outcome 20.  Intelligence quotient may be relevant in epilepsy surgery when etiology is not 
considered, but appears to be of no importance in the subset of patients with MTS-TLE. 
 
5. Seizure frequency 
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In our study, frequency of preoperative habitual seizures (i.e., either complex partial or 
generalized tonic-clonic seizures) was not associated with postoperative seizure outcome in 
patients with MTS-TLE. The data with regard to the role of seizure frequency is inconsistent in 
the literature. In a previous study of 79 patients with TLE (all etiologies) 8, those with more than 
20 seizures per month were significantly less likely to be seizure free after temporal lobectomy 
than the rest of patients (p = 0.009). However, another study found that in patients who had 
anterior temporal lobectomy, preoperative seizure frequency was not associated with 
postoperative seizure frequency, while in non-ATL operations, preoperative seizure frequency of 
≥ 20 seizures per month was associated with frequent postoperative seizures (p = 0.03) 21. Our 
data suggests that the frequency of preoperative habitual seizures does not affect surgery 
outcome in patients with drug-resistant MTS-TLE. 
 
6.    Status epilepticus 
In our study, a history of status epilepticus in the past did not predict postoperative outcome 
in patients with MTS-TLE. This is similar to a previous study of 116 consecutive patients who 
had temporal lobe surgery for drug-resistant epilepsy and MTS 12, and contrasts with the findings 
of another previous study of 118 patients with MTS 13. A large multicenter study would help 
assess this issue. 
 
7. Gender 
In our study, gender did not predict postoperative outcome in patients with MTS-TLE. One 
previous study of 252 patients, who underwent surgical treatment for mesial temporal sclerosis, 
showed that male sex was associated with a reduced risk of seizure recurrence (odds ratio, 0.5; 
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95% confidence interval, 0.3-0.8) 22. However, the same authors in a more recent paper including 
a larger sample size (368 patients) concluded that gender is not a predictor of long-term outcome 
following surgery for temporal lobe epilepsy 23. Other studies 13 have shown similar results to 
ours. 
 
8. Race 
Race was not a predictor of surgery outcome in patients with drug-resistant MTS-TLE, in our 
study. The vast majority of previous studies 23 have the same observation. However, one 
previous study showed a trend for higher rates of seizure recurrence in African-Americans 
compared with white patients 24. That study was limited by the small sample size (i.e., 64 
patients). In general, epidemiologically race does not seem to affect postoperative seizure 
outcome in patients with drug-resistant MTS-TLE. 
 
9. Family history of epilepsy  
A family history of epilepsy did not predict postoperative outcome in patients with MTS-
TLE, in our study. Similar results were reported in a previous study of 118 patients with MTS 13. 
However, another retrospective study of 434 consecutive patients, who underwent TLE surgery, 
found a family history of epilepsy to be a predictor of remission 9. In the latter study, the authors 
investigated a heterogeneous group of patients including those with MTS, tumors or focal 
cortical dysplasia. As said before, better definition of the location of the epileptogenic zone may 
provide better insights. 
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Conclusions 
It is well known that there are several subgroups in TLE (e.g., MTS, TLE plus, pseudo-
TLE, etc.) 25, 26. This research provides further support that differentiating TLE subtypes may 
ultimately lead to a better understanding of the pathophysiology of the temporal lobe epilepsies. 
The potential efficacy of resective surgery in patients with TLE uncontrolled by anti-epileptic 
drugs is undisputed 27-29. However, it is critical to distinguish among different types and 
etiologies of TLE when predicting seizure outcome after surgery.  
Our study places historical risk factors into the equation; however, they are not the only 
predictors of postoperative seizure outcome. It is essential that all factors (e.g., EEG, other 
imaging studies, neuropsychological profile, surgery techniques and volume of resection, etc.) 
are taken into account. In order to improve algorithms for predicting postoperative seizure 
outcome in patients with drug-resistant epilepsy, our findings should be combined with those 
from other studies.  
 
Study limitations 
This was a retrospective study and patient data came from a single institution. Imaging 
techniques have changed with equipment modernization and the general ability to detect 
abnormalities on MRI scans has improved. Other non-historical factors (e.g., resection size) are 
not taken into account in this study. Additionally, resections have evolved somewhat over the 
years, but there has been no difference in treatment strategy. Finally, pathology specimens were 
reviewed by pathologists, but most results were not sufficient to provide a precise pathological 
classification. 
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